PAVmed (PAVM) Long-Term Investments (2024 - 2025)
PAVmed (PAVM) recorded quarterly Long-Term Investments of $34.1 million in Q4 2025, up 7.92% quarter-over-quarter from $31.6 million in Q3 2025, and up 33.09% on a YoY basis from $25.6 million in Q4 2024.
PAVmed (PAVM) Long-Term Investments (2024 - 2025) Analysis & Trends
PAVmed's Long-Term Investments history runs 2 years deep, the most recent figure standing at $34.1 million for Q4 2025.
- In Q4 2025, Long-Term Investments rose 33.09% year-over-year to $34.1 million; the TTM figure through Dec 2025 stood at $34.1 million (up 33.09% YoY), while the FY2025 annual figure was $34.1 million, up 33.09% from the prior year.
- Long-Term Investments was $34.1 million for Q4 2025 at PAVmed, up from $31.6 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $46.6 million in Q1 2025 to a low of $25.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | PAVmed | 2.70 Mn | -10.47 Mn | -703,000.00 | 34.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.12 Mn |
| Sep 30, 2025 | 31.62 Mn |
| Jun 30, 2025 | 36.00 Mn |
| Mar 31, 2025 | 46.64 Mn |
| Dec 31, 2024 | 25.64 Mn |